Plans for a new life science campus through the acquisition and redevelopment of the Shoreway Innovation Center in Belmont are underway following a serious financial commitment through real estate firm CBRE Group.

CBRE announced Wednesday it had arranged $75 million in financing for the acquisition and redevelopment of Shoreway Innovation Center for the borrower, Four Corners Properties, a San Francisco Bay Area real estate company. According to CBRE, the 7-acre property at 1301 Shoreway Road will be redeveloped into a new life sciences campus, likely featuring the construction of two Class A life science buildings, approximately 500,000 to 600,000 aggregate square feet. It will include a multistory parking structure for around 1,500 spaces.

Recommended for you

(0) comments

Welcome to the discussion.

Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.

Thank you for visiting the Daily Journal.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account.

We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.

A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!

Want to join the discussion?

Only subscribers can view and post comments on articles.

Already a subscriber? Login Here